An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Warren, Richard B Mrowietz, Ulrich von Kiedrowski, Ralph Niesmann, Johannes Wilsmann-Theis, Dagmar Ghoreschi, Kamran Zschocke, Ina Falk, Thomas M Blödorn-Schlicht, Norbert Reich, Kristian